Investors seeking reliable dividend income often turn to the midstream energy sector, where companies like Energy Transfer and Enterprise Products Partners stand out. Both firms have a significant presence in North America, but deciding which one offers a better dividend stock can be a challenging
Jaguar Health has unveiled its financial results for the third quarter of 2024, indicating notable strides in growth and development. The announcement revealed a significant increase in net revenue and highlighted the company's continued advancement in its core programs, underscoring its resilience
Evaxion Biotech A/S, a clinical-stage biotech firm listed on Nasdaq under the ticker EVAX, is currently navigating a challenging landscape as it appeals a delisting determination from Nasdaq. This stems from non-compliance with the minimum stockholder equity requirement of $2.5 million stipulated
In an era where electric vehicles (EVs) are becoming the vanguard of the automotive industry, Volkswagen has taken a notable step by investing $5.8 billion in Rivian. This strategic partnership, formulated under their joint venture Rivian and VW Group Technology LLC, exemplifies a strong vote of
Shares of Amgen edged up in premarket trading after the firm's announcement that its experimental obesity drug, MariTide, does not negatively impact bone mineral density. This comes following a more than 7% plunge in stock due to a report by Cantor Fitzgerald analysts, which had cited data implying
In the world of high finance, the recent acquisition of Credit Suisse by UBS has stirred significant regulatory waters, mainly due to concerns over Russian clients tied to the ailing bank Credit Suisse. The U.S. Office of Foreign Assets Control (OFAC), a globally recognized authority on sanctions
